Value Investing - PlanB Flow

Dividend Growth Analysis | Johnson & Johnson (JNJ) – Strong Cash Flow Beyond One-Time Costs

May 9, 2026 by PlanB

Analyzing JNJ, the Dividend King with 63 years of growth. Dividend yield 2.42%, fair value $200.4. Exploring growth potential in Oncology despite one-time noise.

[Analysis] Merck (MRK): Keytruda’s Cash Flow Powers 21 Years of Dividend Growth

May 1, 2026April 30, 2026 by PlanB

Merck (MRK) deep dive: 3.08% forward yield, 21-year dividend growth streak, fair value $141.8 vs. current $111.8. A Strong Buy with a 26% margin of safety. Plan B analysis.